Regarding the RYK knockdown and its effect on cell viability, it is possible that the reduced effect observed in the glioma cell line may be due to differences in the genetic and epigenetic backgrounds of glioma cells compared to HEK cells. The gene discussed is RYK; the disease is glioma.